Search by Drug Name, NDC or Jcode

    J-Code Lookup

    Last Jcode file upload: 1/24/2024

    How To Use This Tool

    This tool allows you to search for the details of a J-code in several ways, including:

    • Drug Name (currently only searching by the generic drug name is supported)
    • HCPCS Code
    • NDC

    For example, you can look up a J-code by NDC. Simply type the NDC into the search box.

    Most J-code detail pages contain a complete HCPCS/NDC crosswalk.

    ***IMPORTANT: Search results will appear at the bottom of the page***

    What Is This Tool?

    Our J-Code lookup tool allows you to find all of the HCPCS (Healthcare Common Procedure Coding System) J-code (and Q-code) drugs and their respective HCPCS Details. In addition, each detail page contains an HCPCS/NDC crosswalk, a billing calculator, and drug information. 

    One of the more popular features of this tool is that it allows you to look up a Jcode by NDC OR by a drug name.

    What Are J-Codes & Q-Codes?

    'J-codes' are drugs that are typically billed through a 'medical' benefit versus a 'pharmacy' benefit under health plans, and are generally not self-administered (i.e. are administered by a health care professional). They consist of chemotherapy drugs and injectable drugs:

    • J0120-J8999 - Drugs Administered Other than Oral Method
    • J9000-J9999 - Chemotherapy Drugs

    Q-Codes are simply temporary codes that the Centers for Medicare & Medicaid Services (CMS) establish for services and supplies that do not yet have a permanent code.

    J-codes and Q-codes are part of the HCPCS Level II code set used for billing for drugs (primarily injectables), supplies, equipment, nonphysician services, and services not represented by CPT codes (Level I HCPCS).  They are often billed along with a procedure-based CPT code. 

    Additional Information

    This tool is free to use but its contents are not available for download or reproduction.

    JCode Directory

    HCPC Drug name
    J9359 Injection, loncastuximab tesirine-lpyl, 0.075 mg
    J9360 Injection, vinblastine sulfate, 1 mg
    J9370 Vincristine sulfate, 1 mg
    J9371 Injection, vincristine sulfate liposome, 1 mg
    J9380 Injection, teclistamab-cqyv, 0.5 mg
    J9381 Injection, teplizumab-mzwv, 5 mcg
    J9390 Injection, vinorelbine tartrate, 10 mg
    J9393 Injection, fulvestrant (teva) not therapeutically equivalent to j9395, 25 mg
    J9394 Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg
    J9395 Injection, fulvestrant, 25 mg
    J9400 Injection, ziv-aflibercept, 1 mg
    J9600 Injection, porfimer sodium, 75 mg
    J9999 Not otherwise classified, antineoplastic drugs
    Q0035 Cardiokymography
    Q0081 Infusion therapy, using other than chemotherapeutic drugs, per visit
    Q0083 Chemotherapy administration by other than infusion technique only (e.g., subcutaneous, intramuscular, push), per visit
    Q0084 Chemotherapy administration by infusion technique only, per visit
    Q0085 Chemotherapy administration by both infusion technique and other technique(s) (e.g., subcutaneous, intramuscular, push), per visit
    Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory
    Q0092 Set-up portable x-ray equipment
    Q0111 Wet mounts, including preparations of vaginal, cervical or skin specimens
    Q0112 All potassium hydroxide (koh) preparations
    Q0113 Pinworm examinations
    Q0114 Fern test
    Q0115 Post-coital direct, qualitative examinations of vaginal or cervical mucous
    Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
    Q0139 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd on dialysis)
    Q0144 Azithromycin dihydrate, oral, capsules/powder, 1 gram
    Q0161 Chlorpromazine hydrochloride, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
    Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen